Przemysława Jarosz-Chobot Selected Research

Lipids

1/2021	The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes.
1/2006	[Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
1/2005	[Lipid disturbances in type 1 diabetes mellitus--cardiovascular risk factor].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Przemysława Jarosz-Chobot Research Topics

Disease

27	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2004
7	Hyperglycemia 04/2022 - 05/2008
5	Type 2 Diabetes Mellitus (MODY) 01/2018 - 09/2008
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2010
4	Diabetes Mellitus 01/2016 - 01/2009
3	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 05/2008
3	Insulin Resistance 01/2013 - 09/2008
2	Infections 01/2021 - 01/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2017 - 01/2010
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2007 - 01/2005
1	Disease Progression 01/2022
1	Body Weight (Weight, Body) 11/2021
1	Diabetes Complications 01/2021
1	IgA Deficiency 01/2021
1	Overweight 01/2021
1	Atrophy 01/2020
1	Weight Gain 10/2018
1	Striae Distensae 01/2017
1	Graves Disease (Basedow Disease) 01/2017
1	Myasthenia Gravis 01/2017
1	Pain (Aches) 02/2016
1	Critical Illness (Critically Ill) 01/2016
1	Ketosis 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 01/2013
1	Autism Spectrum Disorder 01/2011
1	Disease Susceptibility (Diathesis) 01/2010
1	Hemorrhage 01/2010
1	Atherosclerosis 01/2006
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2006

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 11/2021 - 01/2004
7	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 05/2008
4	AntibodiesIBA 01/2019 - 01/2010
4	Blood Glucose (Blood Sugar)IBA 02/2016 - 05/2008
3	GlucokinaseIBA 04/2022 - 01/2017
3	LipidsIBA 01/2021 - 01/2005
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 01/2005
2	ApolipoproteinsIBA 01/2021 - 01/2006
2	AutoantibodiesIBA 01/2017 - 01/2010
2	Metformin (Glucophage)FDA LinkGeneric 01/2009 - 09/2008
2	AndrogensIBA 09/2008 - 01/2006
1	Rituximab (Mabthera)FDA Link 01/2022
1	Trace Elements (Biometals)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ProteomeIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Immunoglobulin D (IgD)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulin IsotypesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	ProinsulinIBA 01/2020
1	N 30IBA 01/2020
1	C-PeptideIBA 01/2019
1	3-aminopropyltrimethoxysilaneIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Inosine Triphosphate (ITP)IBA 01/2017
1	Platelet Membrane GlycoproteinsIBA 01/2017
1	Aligeron (AS 2)IBA 01/2016
1	AntigensIBA 01/2016
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2013
1	Lamin Type A (Lamin A)IBA 01/2013
1	SteroidsIBA 01/2010
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 05/2008
1	Apolipoproteins B (ApoB)IBA 01/2006
1	HDL CholesterolIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Lipoproteins (Lipoprotein)IBA 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2004

Therapy/Procedure

13	Therapeutics 01/2022 - 09/2008
4	Glycemic Control 11/2021 - 05/2008
1	Mediterranean Diet 01/2019
1	Artificial Pancreas 01/2019
1	Immunotherapy 12/2016
1	Catheters 01/2007